These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29246357)

  • 1. 50 Years Ago in The Journal of Pediatrics: Isoniazid Prophylaxis in Tuberculin Reactors.
    Starke J
    J Pediatr; 2018 Jan; 192():52. PubMed ID: 29246357
    [No Abstract]   [Full Text] [Related]  

  • 2. Prior tuberculin skin testing does not boost QuantiFERON-TB results in paediatric contacts.
    Richeldi L; Bergamini BM; Vaienti F
    Eur Respir J; 2008 Aug; 32(2):524-5. PubMed ID: 18669795
    [No Abstract]   [Full Text] [Related]  

  • 3. Interferon-gamma release assay sensitivity in children younger than 5 years is insufficient to replace the use of tuberculin skin test in western countries.
    Chiappini E; Bonsignori F; Mazzantini R; Sollai S; Venturini E; Mangone G; Cortimiglia M; Olivito B; Azzari C; Galli L; de Martino M
    Pediatr Infect Dis J; 2014 Dec; 33(12):1291-3. PubMed ID: 25037039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis Testing in Children.
    Coleman JL; Halton BR; Steele RW
    Clin Pediatr (Phila); 2018 Jul; 57(8):885-888. PubMed ID: 29298496
    [No Abstract]   [Full Text] [Related]  

  • 5. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy.
    Selwyn PA; Sckell BM; Alcabes P; Friedland GH; Klein RS; Schoenbaum EE
    JAMA; 1992 Jul 22-29; 268(4):504-9. PubMed ID: 1619742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in the use of tests to diagnose tuberculosis infection.
    Thompson JE
    N S W Public Health Bull; 2013 Nov; 24(2):92. PubMed ID: 24195852
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents.
    So H; Yuen CS; Yip RM
    Hong Kong Med J; 2017 Jun; 23(3):246-50. PubMed ID: 28126971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Usefulness of IGRA and tuberculin skin test in diagnosis of latent tuberculosis infection in the groups threatened with occupational risk factors - commentary to article of D. Borkowska et al].
    Targowski T
    Pneumonol Alergol Pol; 2014; 82(3):323-5. PubMed ID: 24793157
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of the impact of interferon-gamma release assays on the management of childhood tuberculosis.
    Ling DI; Crépeau CA; Dufresne M; Khan S; Quach C; Dendukuri N; Schwartzman K; Menzies D; Lands LC; Pai M
    Pediatr Infect Dis J; 2012 Dec; 31(12):1258-62. PubMed ID: 22828646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoniazid medication in tuberculin reactors of all ages: a new pattern in prophylaxis of childhood tuberculosis. A preliminary report.
    KASSOWITZ KE
    Wis Med J; 1961 Jul; 60():363-6. PubMed ID: 13751704
    [No Abstract]   [Full Text] [Related]  

  • 11. Purified protein derivatives of tuberculin--past, present, and future.
    Yang H; Kruh-Garcia NA; Dobos KM
    FEMS Immunol Med Microbiol; 2012 Dec; 66(3):273-80. PubMed ID: 22762692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma release assays in children--no better than tuberculin skin testing?
    Ranganathan S; Connell T; Curtis N
    J Infect; 2007 Apr; 54(4):412-3; author reply 414-5. PubMed ID: 16905194
    [No Abstract]   [Full Text] [Related]  

  • 13. Challenges in the use of tests to diagnose tuberculosis infection.
    Marais BJ
    N S W Public Health Bull; 2013 Nov; 24(2):92-3. PubMed ID: 24195853
    [No Abstract]   [Full Text] [Related]  

  • 14. Challenges in the use of tests to diagnose tuberculosis infection.
    Dobler CC
    N S W Public Health Bull; 2013 Nov; 24(2):93. PubMed ID: 24195854
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune response to Mycobacterium tuberculosis in young contacts with discordant immunological test results.
    Jeljeli M; Guérin-El Khourouj V; Pommelet V; Guilmin-Crepon S; Hormi M; Gressens P; Faye A; Sterkers G
    J Infect; 2016 Nov; 73(5):517-520. PubMed ID: 27592265
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of Quantiferon-TB Gold in-Tube in the diagnosis and treatment monitoring of active tuberculosis.
    Bartalesi F; Spinicci M; Mencarini J; Veloci S; Mantella A; Bartoloni A
    Infect Dis (Lond); 2017 Jun; 49(6):474-477. PubMed ID: 28116958
    [No Abstract]   [Full Text] [Related]  

  • 17. [Tuberculosis in Iceland. 1976].
    Sigurdsson S
    Laeknabladid; 2005 Jan; 91(1):69-102. PubMed ID: 16155306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relating Tuberculosis (TB) Contact Characteristics to QuantiFERON-TB-Gold and Tuberculin Skin Test Results in the Toronto Pediatric TB Clinic.
    Rose W; Read SE; Bitnun A; Rea E; Stephens D; Pongsamart W; Kitai I
    J Pediatric Infect Dis Soc; 2015 Jun; 4(2):96-103. PubMed ID: 26407408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tuberculosis prevention].
    Abouda M; Yangui F; Triki M; Kammoun H; Khouani H; Charfi MR
    Rev Pneumol Clin; 2015; 71(2-3):159-67. PubMed ID: 25282572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing for tuberculosis infection.
    Butt A; Kadeishvili K; Aronow WS; Newman T
    Compr Ther; 2008; 34(3-4):151-8. PubMed ID: 19137757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.